IVI Sevilla   Report issue

Academic/Hospital Phase 4
Founded: Seville Spain

Organization Overview

First Clinical Trial
2013
NCT02889341
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IVI RMA Sevilla | IVI Sevilla

Active Ingredients

Drugs in Phase 4 Trials (1)

corifollitropin alfa (1 trial)

Drugs in Other Trials (1)

omega-3 fatty acids (Omacor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2